Literature DB >> 20730008

Cardiac surgery in a patient with essential thrombocythemia: a case report.

B E Schölzel, H Endeman, W Dewilde, A Yilmaz, O de Weerdt, J M Ten Berg.   

Abstract

Patients with essential thrombocythemia (ET) are at increased risk of developing arterial thrombosis. We report a case of a 36-year-man with unstable angina in the presence of occlusion of two coronary arteries with insufficient collateral perfusion. We also found essential thrombocythemia in this patient. The patient underwent coronary artery bypass grafting (CABG). Ten days before surgery, the aspirin was replaced by a prophylactic dose of low-molecular-weight heparin. Postoperative follow-up was complicated by pulmonary embolisms and a cardiac tamponade. We conclude that ET is a risk factor for coronary heart disease that should be treated with aspirin. If a patient needs CABG, aspirin should be continued because of the high risk of thromboembolic events in the high-risk ET patients. (Neth Heart J 2010;18:378-80.).

Entities:  

Keywords:  Aspirin; Case Reports; Coronary Artery Bypass Grafting; Essential; Thrombocythemia

Year:  2010        PMID: 20730008      PMCID: PMC2922787          DOI: 10.1007/BF03091797

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  7 in total

1.  THE MANAGEMENT OF 'LOW-RISK' AND 'INTERMEDIATE-RISK' PATIENTS WITH PRIMARY THROMBOCYTHAEMIA

Authors: 
Journal:  Br J Haematol       Date:  1999-09       Impact factor: 6.998

Review 2.  Thrombocytosis.

Authors:  Andrew I Schafer
Journal:  N Engl J Med       Date:  2004-03-18       Impact factor: 91.245

3.  Essential thrombocythemia. Clinical characteristics and course of 61 cases.

Authors:  R Hehlmann; M Jahn; B Baumann; W Köpcke
Journal:  Cancer       Date:  1988-06-15       Impact factor: 6.860

4.  A long-term retrospective study of young women with essential thrombocythemia.

Authors:  A Tefferi; R Fonseca; D L Pereira; H C Hoagland
Journal:  Mayo Clin Proc       Date:  2001-01       Impact factor: 7.616

5.  Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.

Authors:  Claire N Harrison; Peter J Campbell; Georgina Buck; Keith Wheatley; Clare L East; David Bareford; Bridget S Wilkins; Jon D van der Walt; John T Reilly; Andrew P Grigg; Paul Revell; Barrie E Woodcock; Anthony R Green
Journal:  N Engl J Med       Date:  2005-07-07       Impact factor: 91.245

6.  Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors.

Authors:  K V Watson; N Key
Journal:  Br J Haematol       Date:  1993-02       Impact factor: 6.998

7.  Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey.

Authors:  Marco Ruggeri; Francesco Rodeghiero; Alberto Tosetto; Giancarlo Castaman; Francesca Scognamiglio; Guido Finazzi; Federica Delaini; Caterina Micò; Alessandro M Vannucchi; Elisabetta Antonioli; Valerio De Stefano; Tommaso Za; Luigi Gugliotta; Alessia Tieghi; Maria Gabriella Mazzucconi; Cristina Santoro; Tiziano Barbui
Journal:  Blood       Date:  2007-10-01       Impact factor: 22.113

  7 in total
  7 in total

1.  Off-pump myocardial revascularization in a high-risk patient with essential thrombocythemia.

Authors:  Ahmad K Darwazah; Hamad Madi; Rami Zagha; Yahia Hawash
Journal:  Tex Heart Inst J       Date:  2014-10-01

2.  Effect of collaterals on deaths and re-infarctions in patients with coronary artery disease: a meta-analysis.

Authors:  S Akin; T Yetgin; J J Brugts; A Dirkali; F Zijlstra; T J Cleophas
Journal:  Neth Heart J       Date:  2013-03       Impact factor: 2.380

3.  Pretreatment with hydroxyurea of the patient with essential thrombocythemia followed by coronary artery bypass surgery.

Authors:  Edem Ziadinov; Hilal Al-Sabti; Malik Al-Toubi; Mohammad Salman Siddiqi
Journal:  Oman Med J       Date:  2014-07

Review 4.  Extreme thrombocytosis and cardiovascular surgery: risks and management.

Authors:  Ethan A Natelson
Journal:  Tex Heart Inst J       Date:  2012

5.  Cardiac Surgery Using Hypothermic Circulatory Arrest in a Case of Essential Thrombocythemia.

Authors:  Masahide Enomoto; Takeshi Kinoshita; Yasuo Kondo; Tomoaki Suzuki; Tohru Asai
Journal:  Ann Thorac Cardiovasc Surg       Date:  2018-06-21       Impact factor: 1.520

6.  Coronary artery bypass graft for stent occlusion in a patient with essential thrombocythemia.

Authors:  Nael Al-Sarraf
Journal:  J Surg Case Rep       Date:  2021-12-28

Review 7.  Abdominal surgery in patients with essential thrombocythemia: A case report and systematic review of literature.

Authors:  Yi Zhu; HongGang Jiang; ZhiHeng Chen; BoHao Lu; JiaMing Wu
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.